Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection

Hepatology

Volumn 28, Issue 5, 1998, Pages 1402-1410

  Soni, Paresh N ^a   Brown, David ^b   Saffie, Roggieh ^b   Savage, Kay ^b   Moore, Duncan ^c   Gregoriadis, Gregory ^b   Dusheiko, Geoffrey M ^b  

^a UNIVERSITY OF NATAL   (South Africa)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; PHOSPHOROTHIOATE ANTISENSE OLIGODEOXYNUCLEOTIDE; PHOSPHOROTHIOIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG STABILITY; DUCK; HEPATITIS; HEPATITIS B VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

ANIMALS; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG STABILITY; DUCKS; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B VIRUS, DUCK; LIPOSOMES; METABOLIC CLEARANCE RATE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; THIONUCLEOTIDES; TISSUE DISTRIBUTION;

EID: 0031786508     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280532     Document Type: Article

References (12)

1. Hoofnagle JH. Chronic hepatitis B. N Engl J Med 1990;323:337-339.
2. Hoofnagle JH, Lau D. Chronic viral hepatitis-benefits of current therapies. N Engl J Med 1996;334:1470-1471.
3. Dusheiko GM. Treatment and prevention of chronic viral hepatitis. Pharmacol Therapeut 1995;65:47-73.
4. Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature 1994;372:333-335.
5. Agrawal S. Antisense oligonucleotides as antiviral agents. Trends Biotech 1992;10:152-158.
6. Zamecnik PC, Stephenson ML. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci U S A 1978;75:280-284.
7. Agrawal S, Temsamani J, Galbraith W, Tang J. Pharmacokinetics of antisense oligonucleotides. Clin Pharmacokinet 1995;28:7-16.
8. 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol Pharmacol 1994;45:932-943.
9. Stein CA, Cohen JS. Oligodeoxynucleotides as inhibitors of gene expression: a review. Cancer Res 1988;48:2659-2668.
10. Wagner RW. The state of the art in antisense research. Nat Med 1995;1:1116-1118.
11. Zuckerman AJ. Screening of antiviral drugs for hepadna virus infection in Pekin ducks: a review. J Virol Methods 1987:17:119-126.
12. Robinson WS, Marion PL, Miller RH. The hepadna viruses of animals. Semin Liver Dis 1984;4:347-360.